ClassID:

20912

A61K38/164 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Recent Application in this class:
#601
20170136087
2017-05-18

MULTIFUNCTIONAL BIODEGRADABLE PEG NANOCARRIER-BASED HYDROGELS FOR PREVENTING HIV TRANSMISSION

#602
20170136075
2017-05-18

PHARMACEUTICAL COMPOSITION CONTAINING SPIRULINA MAXIMA EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING RETINAL DISEASES

#603
20170128533
2017-05-11

Protection against stress-mediated damage from ionizing radiation

#604
20170128503
2017-05-11

NEURO-MODULATING PREPARATIONS FOR TREATMENT OF NEUROLOGICAL AND MOOD DISORDERS

#605
20170128360
2017-05-11

COMPOSITIONS AND METHODS FOR TREATING CANCER

#606
20170106059
2017-04-20

REDUCTION OF EGFR THERAPEUTIC TOXICITY

#607
20170101457
2017-04-13

Fusion proteins of collagen-binding domain and parathyroid hormone

#608
20170096457
2017-04-06

ANTI-INFLAMMATORY COMPOUNDS AND METHODS OF USE

#609
20170095568
2017-04-06

Treating bladder tumor cells using fibronectin attachment protein as a target

#610
20170081652
2017-03-23

Near-infrared light-activated proteins

#611
20170081370
2017-03-23

Method for treating prostatitis utilizing the pore-forming protein proaerolysin PRX302

#612
20170080051
2017-03-23

Flagellin related polypeptides and uses thereof

#613
20170072176
2017-03-16

Systems and methods for delivery of a therapeutic agent

#614
20170072030
2017-03-16

Neurotoxins exhibiting shortened biological activity

#615
20170051021
2017-02-23

PEPTIDE AGONISTS OF TOLL-LIKE RECEPTOR 5 LIGAND AND METHOD OF USE

#616
20170044219
2017-02-16

Red-shifted opsin molecules and uses thereof

#617
20170035873
2017-02-09

Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance

#618
20170035837
2017-02-09

Compositions and methods for treating disease using T3SS effector protein (SipA)

#619
20170029474
2017-02-02

POLYPEPTIDE AND ANTI-TUMOR AGENT

#620
20170028046
2017-02-02

Vaccine against colibacillosis

#621
20170028017
2017-02-02

Microcin and uses thereof

#622
20170014486
2017-01-19

Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

#623
20170008953
2017-01-12

Methods of treating and preventing infections and associated conditions

#624
20170007708
2017-01-12

Glycotargeting therapeutics

#625
20170007683
2017-01-12

Tolerogenic compositions comprising and uses thereof

#626
20170007649
2017-01-12

Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease

#627
20160375095
2016-12-29

Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins

#628
20160367629
2016-12-22

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

#629
20160361429
2016-12-15

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

#630
20160354472
2016-12-08

USE OF HUMAN SERUM ALBUMIN TO DECREASE ANTIGENICITY OF THERAPEUTIC PROTEINS

#631
20160339078
2016-11-24

Nutritive polypeptides and formulations thereof, and methods of production and use thereof

#632
20160339077
2016-11-24

Treatment and diagnosis of inflammatory disorders and HIV

#633
20160331816
2016-11-17

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders

#634
20160324982
2016-11-10

Compositions and methods for non-myeloablative conditioning

#635
20160324959
2016-11-10

Aluminum compounds for use in therapeutics and vaccines

#636
20160324920
2016-11-10

Cellular Specific Therapeutic Prion

#637
20160319244
2016-11-03

Modified bacteriophage

#638
20160317614
2016-11-03

Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof

#639
20160310562
2016-10-27

Compositions and methods for the treatment of diseases related to the renin-angiotensin-system

#640
20160296605
2016-10-13

Methods and compositions for treating Huntington's disease

#641
20160296595
2016-10-13

A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT

#642
20160289276
2016-10-06

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

#643
20160287662
2016-10-06

Treatment and diagnosis of ocular disease

#644
20160271209
2016-09-22

ANTIBACTERIAL COMPOSITION

#645
20160264631
2016-09-15

Composition for preventing spp. infection

#646
20160256522
2016-09-08

METHOD FOR ENHANCING WOUND HEALING

#647
20160256379
2016-09-08

Protection against extrinsic skin aging

#648
20160250324
2016-09-01

Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses

#649
20160250283
2016-09-01

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION

#650
20160250282
2016-09-01

Therapeutical tools and methods for treating blindness

#651
20160243191
2016-08-25

Compositions for the Treatment of Cancer, and Methods for Testing and Using the Same

#652
20160237125
2016-08-18

Proteins with diagnostic and therapeutic uses

#653
20160235838
2016-08-18

Vaccines with interleukin-33 as an adjuvant

#654
20160228503
2016-08-11

Compositions and Formulations for Prevention and Treatment of Diabetes and Obesity, and Methods of Production and Use Thereof in Glucose and Caloric Control

#655
20160228500
2016-08-11

Immunogenic Polypeptides and Monoclonal Antibodies

#656
20160213771
2016-07-28

Compositions, methods and kits for eliciting an immune response

#657
20160206713
2016-07-21

Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy

#658
20160206711
2016-07-21

Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen

#659
20160206690
2016-07-21

USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER

#660
20160201067
2016-07-14

Composition for Enhancing Transgene Expression in Eukaryotic Cells and Method for Enhancing Production of a Target Protein Encoded by a Transgene

#661
20160193287
2016-07-07

Uses of BT lipopeptides as therapeutics for obesity and related diseases

#662
20160185839
2016-06-30

Polymeric forms of H-NOX proteins

#663
20160175422
2016-06-23

Combination neisserial compositions

#664
20160169921
2016-06-16

Modulating bacterial MAM polypeptides in pathogenic disease

#665
20160168233
2016-06-16

Cellular factors involved in the cytotoxicity of leukocidins: novel therapeutic targets

#666
20160166671
2016-06-16

Clostridium Difficile Compositions and Methods of Use

#667
20160166644
2016-06-16

Protection against apoptosis from ionizing radiation

#668
20160158312
2016-06-09

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

#669
20160151453
2016-06-02

Methods and pharmaceutical compositions for the treatment of bacterial infections

#670
20160151452
2016-06-02

Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof

#671
20160151283
2016-06-02

HYALUROSOMES, THEIR USE IN TOPICAL COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS

#672
20160145590
2016-05-26

Cytolethal distending toxin subunit B conjugated or fused to toxin lethal factor

#673
20160145338
2016-05-26

Human monoclonal antibodies specific for CD22

#674
20160144014
2016-05-26

Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease

#675
20160137702
2016-05-19

GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

#676
20160137701
2016-05-19

Secretagogues derived from oxalobacter formigenes

#677
20160129095
2016-05-12

Immunostimulatory combinations

#678
20160120961
2016-05-05

TREATMENT OF MERKEL CELL POLYOMAVIRUS INFECTION

#679
20160120807
2016-05-05

CELL-SURFACE DECORATION WITH ACTIVE AGENTS

#680
20160114033
2016-04-28

Aluminum compounds for use in therapeutics and vaccines

#681
20160108429
2016-04-21

-Prom mediated surface expression of avidin/streptavidin

#682
20160097031
2016-04-07

Compositions of active Wnt protein

#683
20160096035
2016-04-07

System and method for optogenetic therapy

#684
20160095898
2016-04-07

YERSINIA OUTER PROTEIN M (YOPM) IN THE TREATMENT OF PSORIASIS

#685
20160082125
2016-03-24

Salipro particles

#686
20160082104
2016-03-24

Methods and Compositions for the Treatment of Proliferative and Pathogenic Diseases

#687
20160082077
2016-03-24

Flagellin related polypeptides and uses thereof

#688
20160068590
2016-03-10

POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING GRAM POSITIVE POLYPEPTIDES AND METHODS OF USE

#689
20160060352
2016-03-03

COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA

#690
20160060305
2016-03-03

Use of flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

#691
20160051838
2016-02-25

System and method for optogenetic therapy

#692
20160051837
2016-02-25

System and method for optogenetic therapy

#693
20160051836
2016-02-25

System and method for optogenetic therapy

#694
20160051831
2016-02-25

System and method for optogenetic therapy

#695
20160046677
2016-02-18

exotoxin A with less immunogenic B cell epitopes

#696
20160045765
2016-02-18

System and method for optogenetic therapy

#697
20160045764
2016-02-18

System and method for optogenetic therapy

#698
20160039890
2016-02-11

INTRAOCULAR ANGIOGENESIS INHIBITOR AND USES THEREOF

#699
20160038765
2016-02-11

System and method for optogenetic therapy

#700
20160038758
2016-02-11

System and method for optogenetic therapy

#701
20160038755
2016-02-11

System and method for optogenetic therapy

#702
20160038571
2016-02-11

Method and compositions for treatment of calcineurin-related diseases

#703
20160038564
2016-02-11

Compositions and methods for the treatment of disorders involving epithelial cell apoptosis

#704
20160031947
2016-02-04

Cupredoxin derived transport agents and methods of use thereof

#705
20160030585
2016-02-04

Fatty acids and their use in conjugation to biomolecules

#706
20160030511
2016-02-04

Neurotoxins exhibiting shortened biological activity

#707
20160030510
2016-02-04

METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES WITH INHIBITORS OF MICROTUBULE AFFINITY REGULATING KINASE

#708
20160024167
2016-01-28

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#709
20160022767
2016-01-28

Protein particles comprising disulfide crosslinkers and uses

#710
20160017034
2016-01-21

COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER

#711
20160017008
2016-01-21

Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin

#712
20160015834
2016-01-21

Constructs containing multiple expression cassettes for cancer therapy

#713
20160015651
2016-01-21

Hard capsule formulation

#714
20160009768
2016-01-14

Modified toxins

#715
20150376241
2015-12-31

Flagellin related polypeptides and uses thereof

#716
20150374860
2015-12-31

Treatment of metastatic tumors

#717
20150374780
2015-12-31

Compositions and methods to prevent cancer with cupredoxins

#718
20150366937
2015-12-24

Methods to treat inflammation of the lung

#719
20150359844
2015-12-17

Antimicrobial bacteria strains and uses thereof

#720
20150344846
2015-12-03

Compositions of active Wnt protein

#721
20150343088
2015-12-03

Antibody recognizing folate receptors α and β

#722
20150343040
2015-12-03

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

#723
20150335705
2015-11-26

ANTI-INFLAMMATORY PEPTIDES

#724
20150328284
2015-11-19

COMPOSITIONS AND METHODS COMPRISING TOLL LIKE RECEPTOR (TLR) STIMULATING AGENTS FOR PROPHYLAXIS AND THERAPY FOR DAMAGE TO DERMAL EPITHELIUM

#725
20150321586
2015-11-12

Powered stowable vehicle seat and associated seat frame assembly

#726
20150320883
2015-11-12

Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals

#727
20150320830
2015-11-12

Anti-microbial agent from sp. and methods and uses thereof

#728
20150320829
2015-11-12

Broad Spectrum Bacteriocin for Control of Unwanted Bacteria

#729
20150320743
2015-11-12

INJECTABLE COMBINATION OF ADRENERGIC RECEPTOR AGONISTS WITH FILLERS, FOR DECREASING SKIN REACTIONS DUE TO INJECTION

#730
20150313973
2015-11-05

Formulations of biologics for intravesical instillation

#731
20150313958
2015-11-05

Daptomycin formulations and uses thereof

#732
20150309023
2015-10-29

Use of amino acid sequences from or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#733
20150307582
2015-10-29

Engineered receptors and their use

#734
20150306168
2015-10-29

Methods of protecting against apoptosis using lipopeptides

#735
20150291667
2015-10-15

CHIMERA COMPRISING BACTERIAL CYTOTOXIN AND METHODS OF USING THE SAME

#736
20150290331
2015-10-15

Glycoconjugates and their use as potential vaccines against infection by

#737
20150290284
2015-10-15

IDEOTYPICALLY MODULATED PHARMACOEFFECTORS FOR SELECTIVE CELL TREATMENT

#738
20150290283
2015-10-15

LIGHT-SENSITIVE PUMPS FOR SUPPRESSION OF CARDIAC ACTIVITY

#739
20150283203
2015-10-08

METHOD FOR TREATING PROSTATITIS UTILIZING PORE-FORMING PROTEIN PROAEROLYSIN

#740
20150274814
2015-10-01

Methods of treating and preventing infections and associated conditions

#741
20150265674
2015-09-24

Poly-glutamic acid anti-anthrax compositions and methods for using the same

#742
20150258216
2015-09-17

MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY

#743
20150238565
2015-08-27

Bacteriocin derived from

#744
20150231068
2015-08-20

Treatment of Migraine Headaches with Presynaptic Neurotoxin

#745
20150218644
2015-08-06

Therapy with enterotoxin to treat ovarian and uterine cancer

#746
20150210757
2015-07-30

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

#747
20150209393
2015-07-30

Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism

#748
20150202255
2015-07-23

Treatment and diagnosis of inflammatory disorders and HIV

#749
20150202254
2015-07-23

Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

#750
20150192567
2015-07-09

Red-shifted opsin molecules and uses thereof

#751
20150190463
2015-07-09

Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium

#752
20150182587
2015-07-02

METHODS FOR TREATING REPERFUSION INJURIES

#753
20150174265
2015-06-25

REVERSIBLE MASKING OF PORE-FORMING PROTEINS FOR MACROMOLECULAR DELIVERY

#754
20150174199
2015-06-25

Gluten-related disorders

#755
20150165029
2015-06-18

THERAPEUTIC COMPOSITIONS

#756
20150165009
2015-06-18

TLR5 ligands, therapeutic methods, and compositions related thereto

#757
20150164984
2015-06-18

Colicins for Treating Bacterial Infections

#758
20150164983
2015-06-18

Microcin and uses thereof

#759
20150157688
2015-06-11

COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-KB

#760
20150157686
2015-06-11

Treatments of oxidative stress conditions

#761
20150150625
2015-06-04

Systems and methods for delivery of a therapeutic agent

#762
20150147350
2015-05-28

Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor

#763
20150139939
2015-05-21

Cancer stem cell targeted cancer vaccines

#764
20150132367
2015-05-14

YOPM AS DELIVERY VEHICLE FOR CARGO MOLECULES AND AS BIOLOGICAL THERAPEUTIC FOR IMMUNOMODULATION OF THE INFLAMMATORY REACTIONS

#765
20150125503
2015-05-07

Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features

#766
20150111814
2015-04-23

Compositions for promoting HIV-1 virolysis and methods using same

#767
20150111813
2015-04-23

Biofilm prevention, disruption and treatment with bacteriophage lysin

#768
20150110827
2015-04-23

FUSION PROTEINS AND METHODS OF USE

#769
20150110735
2015-04-23

High-speed centrifugal mixing devices and methods of use

#770
20150105333
2015-04-16

LATENT HUMAN IMMUNODEFICIENCY VIRUS REACTIVATION

#771
20150079131
2015-03-19

Prevention of inflammatory disorders in domestic non-human mammals

#772
20150072931
2015-03-12

Modulating apoptosis

#773
20150071957
2015-03-12

Polypeptide and immune modulation

#774
20150056246
2015-02-26

Subunit vaccine delivery platform for robust humoral and cellular immune responses

#775
20150056163
2015-02-26

Leukotoxin E/D as a new anti-inflammatory agent and microbicide

#776
20150051146
2015-02-19

HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway

#777
20150050256
2015-02-19

Class I and II lantibiotics from geobacillus thermodenitrificans

#778
20150044146
2015-02-12

Replacement therapy for dental caries

#779
20150044145
2015-02-12

Materials and methods for treatment of cystic fibrosis and for induction of ion secretion

#780
20150038557
2015-02-05

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#781
20150031858
2015-01-29

Methods of stimulating protective immunity employing Dengue viral antigens

#782
20150030575
2015-01-29

Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes

#783
20150023997
2015-01-22

Compositions, methods and therapies for administering antigen peptide

#784
20150023937
2015-01-22

Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted antigen intensity, increasing antitumor efficacy

#785
20150011474
2015-01-08

Polypeptides binding to human complement C5

#786
20140378658
2014-12-25

NEUROLOGICAL THERAPIES

#787
20140371130
2014-12-18

Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins

#788
20140357842
2014-12-04

outer protein M (YopM) in the treatment of psoriasis

#789
20140348807
2014-11-27

PROCESS FOR THE PREPARATION OF A BIOMASS COMPRISING PLANTARICIN AND USES THEREOF IN MEDICAL FIELD

#790
20140341930
2014-11-20

Systems and methods for diminishing cell growth and inducing selective killing of target cells

#791
20140323430
2014-10-30

Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns

#792
20140315788
2014-10-23

Methods for improving muscle and heart function

#793
20140314890
2014-10-23

COMBINATION ANTI-CANCER THERAPY

#794
20140308744
2014-10-16

Compositions of active Wnt protein

#795
20140308240
2014-10-16

Therapeutic agent for infections, and treatment method using same

#796
20140302097
2014-10-09

Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors

#797
20140294900
2014-10-02

Flagellin related polypeptides and uses thereof

#798
20140287990
2014-09-25

COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS

#799
20140286930
2014-09-25

Treatment of mammalian physiological reaction of IgE antibodies present in said mammal upon contact with the corresponding antigen

#800
20140274879
2014-09-18

Methods of use for an antimicrobial peptide

#801
20140255376
2014-09-11

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

#802
20140248348
2014-09-04

Use of flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

#803
20140248260
2014-09-04

Use of Toll-Like Receptor agonist for treating cancer

#804
20140242073
2014-08-28

CARTILAGE/BONE DESTRUCTION SUPPRESSOR

#805
20140242032
2014-08-28

Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene

#806
20140235532
2014-08-21

Immunogenic heat stable enterotoxin

#807
20140234256
2014-08-21

Commensal bacteria as singal mediators within a mammalian host

#808
20140227313
2014-08-14

Group A streptococcal M-related proteins and methods of use

#809
20140220037
2014-08-07

Methods for treating tourniquet-induced injuries

#810
20140213529
2014-07-31

exotoxin A with less immunogenic B cell epitopes

#811
20140206601
2014-07-24

Methods and pharmaceutical compositions for the treatment of respiratory tract infections

#812
20140205617
2014-07-24

Compositions and Methods for Treatment of Neoplastic Disease

#813
20140193458
2014-07-10

Method of vaccination comprising a histone deacetylase inhibitor

#814
20140187475
2014-07-03

Lantibiotic Compositions and Methods For Preventing or Treating Mastitis

#815
20140186369
2014-07-03

METHOD OF MODULATING NEOVASCULARIZATION

#816
20140179617
2014-06-26

Cytotoxic factors for modulating cell death

#817
20140179594
2014-06-26

STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK

#818
20140171494
2014-06-19

Use of integrase for targeted gene expression

#819
20140165226
2014-06-12

Antimicrobial agents from microbial genomes

#820
20140147426
2014-05-29

Anticaries compositions and probiotics/prebiotics

#821
20140120191
2014-05-01

METHOD OF TREATING A DISORDER ASSOCIATED WITH SEQUESTERED BACTERIA

#822
20140120169
2014-05-01

Device and method for encapsulation of hydrophilic materials

#823
20140113873
2014-04-24

Method of increasing epithelial cell proliferation with chitin binding protein

#824
20140113865
2014-04-24

Use of pertussis toxin as a therapeutic agent

#825
20140099331
2014-04-10

Zwitterionic immunomodulators for the treatment of asthma and allergy

#826
20140093575
2014-04-03

Stable layer-by-layer coated particles

#827
20140093539
2014-04-03

Protein A compositions and methods of use

#828
20140093477
2014-04-03

Modulating bacterial MAM polypeptides in pathogenic disease

#829
20140088020
2014-03-27

Composition and Methods for Treatment of Cancer

#830
20140086996
2014-03-27

WATER-SOLUBLE DRUG CARRIER AND PROCESS FOR PRODUCING THE SAME

#831
20140086901
2014-03-27

Inhibition of Post-Radiation Tumor Growth

#832
20140073586
2014-03-13

Compositions for the treatment of cancer, and methods for testing and using the same

#833
20140073578
2014-03-13

Combination therapy with leukotoxin

#834
20140066363
2014-03-06

CARBOHYDRATE NANOPARTICLES FOR PROLONGED EFFICACY OF ANTIMICROBIAL PEPTIDE

#835
20140056820
2014-02-27

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

#836
20140051643
2014-02-20

Anticancer agent

#837
20140051638
2014-02-20

Targeted delivery of botulinum toxin to the sphenopalatine ganglion

#838
20140045750
2014-02-13

Methods of protecting against apoptosis using lipopeptides

#839
20140037683
2014-02-06

Methods of stimulating protective immunity employing Dengue viral antigens

#840
20140037668
2014-02-06

COMBINATION NEISSERIAL COMPOSITIONS

#841
20140030284
2014-01-30

Compositions comprising chimeric OSPA molecules and methods of use thereof

#842
20140010862
2014-01-09

MULTIFUNCTIONAL BIODEGRADABLE PEG NANOCARRIER-BASED HYDROGELS FOR PREVENTING HIV TRANSMISSION

#843
20140010756
2014-01-09

COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER

#844
20130345114
2013-12-26

Agent for treating allergic or hypersensitivity condition

#845
20130337013
2013-12-19

Recombinant bacterium comprising a toxin/antitoxin system

#846
20130331330
2013-12-12

METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES WITH INHIBITORS OF MICROTUBULE AFFINITY REGULATING KINASE

#847
20130324462
2013-12-05

Method of Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides

#848
20130323215
2013-12-05

Tumour cytotoxic agent and methods thereof

#849
20130315922
2013-11-28

Method for inducing lymphoid tissue and modulating intestinal homeostasis

#850
20130315890
2013-11-28

Treatment of traumatic-induced migraine headache

#851
20130315860
2013-11-28

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#852
20130310446
2013-11-21

MIR-21 promoter driven targeted cancer therapy

#853
20130303948
2013-11-14

Systems and methods for delivery of a therapeutic agent

#854
20130302313
2013-11-14

Hexon Tat-PTD modified adenovirus and uses thereof

#855
20130296259
2013-11-07

PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM NEUROTOXIN

#856
20130295121
2013-11-07

Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin

#857
20130288952
2013-10-31

Polypeptides and Immunizing Compositions Containing Gram Positive Polypeptides and Methods of Use

#858
20130288374
2013-10-31

Protein delivery system to generate induced pluripotent stem (iPS) cells or tissue-specific cells

#859
20130280295
2013-10-24

Aluminum compounds for use in therapeutics and vaccines

#860
20130266583
2013-10-10

antigens

#861
20130259834
2013-10-03

Genetically modified bacterium

#862
20130252902
2013-09-26

Type A2 botulinum toxin preparation

#863
20130252260
2013-09-26

Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom

#864
20130251830
2013-09-26

THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN

#865
20130243723
2013-09-19

Vaccine immunotherapy

#866
20130236497
2013-09-12

TREATING NEOPLASMS WITH NEUROTOXIN

#867
20130236488
2013-09-12

polypeptides useful in the prevention of periodontal disease

#868
20130236446
2013-09-12

TREATMENT OF MIGRAINE HEADACHE WITH DIFFUSION OF TOXIN IN NON-MUSCLE RELATED AREAS OF THE MOUTH

#869
20130236444
2013-09-12

Treatment of migraine headache with diffusion of toxin in non-muscle related foraminal sites

#870
20130225480
2013-08-29

Method of treating chronic obstructive pulmonary disease

#871
20130217859
2013-08-22

Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870

#872
20130210731
2013-08-15

Compositions and methods to control angiogenesis with cupredoxins

#873
20130203653
2013-08-08

BACTERIAL-DERIVED BLIS FOR TREATMENT OF ACNE

#874
20130196011
2013-08-01

Antimicrobial bacteria strains and uses thereof

#875
20130195893
2013-08-01

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

#876
20130195765
2013-08-01

Method for treating and diagnosing cancer by using cell-derived microvesicles

#877
20130190224
2013-07-25

Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides

#878
20130184200
2013-07-18

Immunogenic Polypeptides and Monoclonal Antibodies

#879
20130183245
2013-07-18

Methods of treating cerebral amyloid angiopathy

#880
20130171194
2013-07-04

Stable formulations of rLP2086 antigens

#881
20130171124
2013-07-04

Compositions and methods of treating head and neck cancer

#882
20130156737
2013-06-20

Secretion System and Methods for its Use

#883
20130150307
2013-06-13

Methods for treating depression

#884
20130150286
2013-06-13

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS

#885
20130143316
2013-06-06

Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer

#886
20130143268
2013-06-06

Method of producing the polypeptide for treating virus-induced cancer

#887
20130137630
2013-05-30

Formulations for infusion of type B lantibiotics

#888
20130130988
2013-05-23

Macromolecular complex of bacterial origin and use of said macromolecular complex for preventing and treating inflammatory rheumatism

#889
20130129751
2013-05-23

Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302)

#890
20130115228
2013-05-09

Immunotherapy comprising TLR9 ligand and CD40 ligand

#891
20130115195
2013-05-09

Anti-aging formulations

#892
20130095094
2013-04-18

Assay for measuring inflammatory molecules in orally ingestible samples

#893
20130084292
2013-04-04

Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease

#894
20130084247
2013-04-04

Compositions and methods to prevent cancer with cupredoxins

#895
20130072427
2013-03-21

GPR 119 MODULATORS

#896
20130059790
2013-03-07

PROCESS FOR THE PREPARATION OF A BIOMASS COMPRISING PLANTARICIN AND USES THEREOF IN MEDICAL FIELD

#897
20130059374
2013-03-07

Novel Therapeutical Tools and Methods for Treating Blindness

#898
20130052164
2013-02-28

Isolated nucleotide molecule and method of sensing and killing of pathogenic microorganism

#899
20130045163
2013-02-21

Treatment of metastatic tumors

#900
20130039885
2013-02-14

Leukotoxin E/D as a new anti-inflammatory agent and microbicide